All Articles

Review Article 
Narrative review: secondary central nervous system lymphoma
Sara Steffanoni, Jeanette Karin Doorduijin
Annals of Lymphoma  
2021;
5:
5  
Review Article 
Antibiotic treatment for bacteria-associated extranodal marginal zone lymphoma
Marianna Sassone, Maurilio Ponzoni, Andrés J. M. Ferreri
Annals of Lymphoma  
2021;
5:
4  
Review Article 
Novel targeted agents for follicular lymphoma
Connie Lee Batlevi, Franck Morschhauser
Annals of Lymphoma  
2021;
5:
3  
Review Article 
Treatment of elderly patients with primary CNS lymphoma
Nicolas Martinez-Calle, Lisa K. Isbell, Kate Cwynarski, Elisabeth Schorb
Annals of Lymphoma  
2021;
5:
2  
Review Article 
Epidemiology of marginal zone lymphoma
James R. Cerhan, Thomas M. Habermann
Annals of Lymphoma  
2021;
5:
1  
Review Article 
The complex pathology and differential diagnosis of splenic and nodal marginal zone lymphoma
Manuela Mollejo, Miguel A. Piris
Annals of Lymphoma  
2020;
4:
18  
Review Article 
Primary vitreoretinal lymphoma: recent advances and literature review
Chiara Giuffrè, Matteo Menean, Giulio M. Modorati, Alessandro Marchese, Maria Vittoria Cicinelli, Francesco Bandello, Elisabetta Miserocchi
Annals of Lymphoma  
2020;
4:
17  
Review Article 
Radiation therapy of extranodal marginal zone lymphomas
Letizia Deantonio, Chelsea C. Pinnix, Richard Tsang
Annals of Lymphoma  
2020;
4:
16  
Review Article 
Pathology of extranodal marginal zone lymphoma at different anatomic sites
Andrew Wotherspoon
Annals of Lymphoma  
2020;
4:
15  
Review Article 
Primary central nervous system lymphoma: consolidation strategies
Carole Soussain, Andrés J. M. Ferreri
Annals of Lymphoma  
2020;
4:
14  
Review Article 
Present role and future perspective of PET-CT in marginal zone lymphoma
Luca Ceriani, Michel Meignan
Annals of Lymphoma  
2020;
4:
13  
Review Article 
Tailored treatment in mantle cell lymphoma
Simone Ferrero, Daniele Grimaldi, Martin Dreyling, on behalf of European Mantle Cell Lymphoma Network
Annals of Lymphoma  
2020;
4:
12  
Review Article 
Report from the Lymphoma Research Foundation Adolescent and Young Adult (AYA) Lymphoma Scientific Workshop, May 2019
Kara M. Kelly, Thomas M. Habermann, Catherine Bollard, Kieron M. Dunleavy, Thomas Gross, Tara Henderson, Ann S. LaCasce, Christian Steidl
Annals of Lymphoma  
2020;
4:
11  
Review Article 
The B cell receptor in marginal zone lymphoma ontogeny and evolution
Laura Zaragoza-Infante, Andreas Agathangelidis, Maria Papaioannou, Anastasia Chatzidimitriou, Kostas Stamatopoulos
Annals of Lymphoma  
2020;
4:
10  
Review Article 
Targeting pathogenic mechanisms in marginal zone lymphoma: from concepts and beyond
Jennifer K. Lue, Owen A. O’Connor, Francesco Bertoni
Annals of Lymphoma  
2020;
4:
7  
Review Article 
Prognostic factors and risk of transformation in marginal zone lymphoma
Juan Pablo Alderuccio, Izidore S. Lossos
Annals of Lymphoma  
2020;
4:
6  
Review Article 
A narrative review of survival normalization in non-Hodgkin lymphoma: useful for better patient counselling and an endpoint for clinical trials?
Lasse H. Jakobsen, Andreas K. Øvlisen, Sandra Eloranta, Martin Bøgsted, Marianne T. Severinsen, Karin E. Smedby, Matthew J. Maurer, Tarec C. El-Galaly
Annals of Lymphoma  
2020;
4:
5  
Review Article 
Minimal residual disease (MRD) in mantle cell lymphoma
Marco Ladetto, Rita Tavarozzi, Christiane Pott
Annals of Lymphoma  
2020;
4:
4  
Editorial 
Growing (up) together: understanding lymphoma in the adolescent and young adult population
Bruce D. Cheson, Meghan E. Gutierrez
Annals of Lymphoma  
2020;
4:
3  
Review Article 
Recent advances in the first-line treatment of mantle cell lymphoma
Morgane Cheminant, Martin Dreyling, Olivier Hermine
Annals of Lymphoma  
2020;
4:
2  
Review Article 
Targeting CDK4/6 in mantle cell lymphoma
Christina Lee, Xiangao Huang, Maurizio Di Liberto, Peter Martin, Selina Chen-Kiang
Annals of Lymphoma  
2020;
4:
1  
Editorial 
Better understanding and new challenges in high grade lymphomas
Astrid Pavlovsky
Annals of Lymphoma  
2019;
3:
13  
Case Report 
PD-L1 expression and response to nivolumab in a case of relapsed/refractory lymphomatoid granulomatosis
Jonathan Weiss, Tera Mayer, Noah Brown, Ryan A. Wilcox
Annals of Lymphoma  
2019;
3:
12